Completed PHASE4 INTERVENTIONAL 1-arm NCT01373567

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

An Open Label, Non-comparative, Multicentre, Phase IV Study to Evaluate the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

Sponsor: Piramal Enterprises Limited

Conditions Plaque Psoriasis

Interventions TINEFCON

Updated 7 times since 2017 Last updated: Nov 21, 2012 Started: Dec 31, 2010 Primary completion: Feb 29, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01373567, this PHASE4 trial focuses on Plaque Psoriasis and remains completed. Sponsored by Piramal Enterprises Limited, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2025 — Jan 2026 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Piramal Enterprises Limited

Data source: Piramal Enterprises Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ahmedabad, India , Bangalore, India , Chandigarh, India , Coimbatore, India , Hyderabad, India , Indore, India , Jaipur, India , Lucknow, India , Mohali, India , Mumbai, India and 5 more locations